We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Molly Campbell is a senior science writer at Technology Networks. She holds a first-class honors degree in neuroscience. In 2021 Molly was shortlisted for the Women in Journalism Georgina Henry Award.
The use of living sources and materials in the manufacturing of biological products means the development process from concept to therapeutic is more complex than chemically synthesized drugs. Consequently, a whole host of tools can be adopted at different stages of the biopharmaceutical development pipeline for varying types of analyses.
Download this infographic to learn about:
The heterogeneity of biological products
The toolbox of analytical techniques that can be used at different stages of the biopharmaceutical R&D timeline
Molly Campbell is a senior science writer at Technology Networks. She holds a first-class honors degree in neuroscience. In 2021 Molly was shortlisted for the Women in Journalism Georgina Henry Award.